Clinical Trials in Tennessee

Showing 12741-12760 of 17,345 trials

Bisphosphonate Treatment of Osteogenesis Imperfecta

NCT00063479

The primary purpose of this trial is to evaluate whether the investigational medication is safe, effective and has the ability to increase spine bone density in osteogenesis imperfecta (OI) patients.

Osteogenesis Imperfecta

Novartis Pharmaceuticals158 participantsStarted Jun 2003

Los Angeles, California, United States • Wilmington, Delaware, United States • Boise, Idaho, United States +7 more locations

TERMINATEDNA29 miles

Topical Silver for Prevention of Wound Infection After Cesarean Delivery

NCT01169064

A common concern in any surgical procedure is the occurrence of infection. Silver-containing treatments are popular and used in wound treatment; however, there is presently little evidence of the effectiveness of silver-containing treatment for the prevention of obstetrical wound infection. We plan to investigate the rate of infection in women experiencing cesarean sections at Vanderbilt University Medical Center (VUMC) by comparing the infection rate based on a randomized choice of silver-containing wound dressings to soft cloth adhesive wound dressings.

Wound Infection

Vanderbilt University475 participantsStarted Jul 2010

Nashville, Tennessee, United States

COMPLETEDPhase 129 miles

A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects

NCT01980589

The primary objective was to determine the maximum tolerated dose of carfilzomib given twice weekly in combination with cyclophosphamide and dexamethasone for patients with newly diagnosed multiple myeloma.

Multiple Myeloma

Amgen22 participantsStarted Aug 2013

Encinitas, California, United States • West Hollywood, California, United States • Whittier, California, United States +6 more locations

Bisphosphonate Treatment of Osteogenesis Imperfecta

Topical Silver for Prevention of Wound Infection After Cesarean Delivery

A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects

Find Trials by Condition in Tennessee

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Lethargic Depression Study

Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects

A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment

A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy

GW873140 In Combination With Combivir In HIV Infected Subjects

Dose Ranging of GSK2336805 in Combination Therapy

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations

A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia

An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome

A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis

Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients

BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis